亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging

阶段(地层学) 癌症 AJCC分段系统 医学 癌症分期 监测、流行病学和最终结果 流行病学 腺癌 肿瘤科 结直肠癌 癌症登记处 内科学 外科 登台系统 古生物学 生物
作者
J. B. O'Connell,Melinda A. Maggard,Clifford Y. Ko
出处
期刊:Journal of the National Cancer Institute [Oxford University Press]
卷期号:96 (19): 1420-1425 被引量:1584
标识
DOI:10.1093/jnci/djh275
摘要

Background: The recently revised American Joint Committee on Cancer (AJCC) sixth edition cancer staging system increased the stratification within colon cancer stages II and III defined by the AJCC fifth edition system. Using nationally representative Surveillance, Epidemiology, and End Results (SEER) data, we compared survival rates associated with colon cancer stages defined according to both AJCC systems. Methods: Using SEER data (from January 1, 1991, through December 31, 2000), we identified 119 363 patients with colon adenocarcinoma and included all patients in two analyses by stages defined by AJCC fifth and sixth edition systems. Tumors were stratified by SEER’s “extent of disease” and “number of positive [lymph] nodes” coding schemes. Kaplan–Meier analyses were used to compare overall and stage-specific 5-year survival. All statistical tests were two-sided. Results: Overall 5-year survival was 65.2%. According to stages defined by the AJCC fifth edition system, 5-year stage-specific survivals were 93.2% for stage I, 82.5% for stage II, 59.5% for stage III, and 8.1% for stage IV. According to stages defined by the AJCC sixth edition system, 5-year stage-specific survivals were 93.2% for stage I, 84.7% for stage IIa, 72.2% for stage IIb, 83.4% for stage IIIa, 64.1% for stage IIIb, 44.3% for stage IIIc, and 8.1% for stage IV. Under the sixth edition system, 5-year survival was statistically significantly better for patients with stage IIIa colon cancer (83.4%) than for patients with stage IIb disease (72.2%) (P<.001). Conclusions: The AJCC sixth edition system for colon cancer stratifies survival more distinctly than the fifth edition system by providing more substages. The association of stage IIIa colon cancer with statistically significantly better survival than stage IIb in the new system may reflect current clinical practice, in which stage III patients receive chemotherapy but stage II patients generally do not.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
4秒前
七慕凉发布了新的文献求助10
5秒前
咸鱼完成签到,获得积分10
8秒前
Mitty发布了新的文献求助10
11秒前
大模型应助七慕凉采纳,获得10
12秒前
大模型应助乐观的花生采纳,获得10
16秒前
alpha发布了新的文献求助10
18秒前
天成完成签到 ,获得积分10
22秒前
丰D完成签到 ,获得积分10
22秒前
所所应助热情曲奇采纳,获得10
26秒前
SciGPT应助ATX采纳,获得30
35秒前
千秋岁完成签到 ,获得积分10
38秒前
现代的南风完成签到 ,获得积分10
39秒前
坚强觅珍完成签到 ,获得积分10
42秒前
白华苍松发布了新的文献求助10
55秒前
tingting完成签到 ,获得积分10
1分钟前
Akim应助lll采纳,获得10
1分钟前
林初一完成签到 ,获得积分10
1分钟前
我是老大应助taeyeon采纳,获得10
1分钟前
寒霜扬名完成签到 ,获得积分10
1分钟前
viktornguyen完成签到,获得积分10
1分钟前
领导范儿应助ZHANG采纳,获得10
1分钟前
fn完成签到,获得积分10
1分钟前
attention完成签到,获得积分10
1分钟前
1分钟前
1分钟前
AprilLeung完成签到 ,获得积分10
1分钟前
Copyright应助科研通管家采纳,获得10
1分钟前
1分钟前
英俊的铭应助科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
alpha发布了新的文献求助10
1分钟前
小透明发布了新的文献求助10
1分钟前
ATX发布了新的文献求助30
1分钟前
qing完成签到 ,获得积分10
1分钟前
Lucas应助ZZX采纳,获得10
1分钟前
ZHANG发布了新的文献求助10
1分钟前
高分求助中
液晶指向矢仿真分析数据集 8888
Invited Discussant 63O and 64O 1000
Ideology and Meaning-Making under the Putin Regime 750
Petrology and Plate Tectonics 500
Writing Systems 500
A Handbook of User Experience Research & Design in Libraries 400
Understanding Modeling and Simulation of Polymerization Reactions 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6870326
求助须知:如何正确求助?哪些是违规求助? 8572210
关于积分的说明 18222928
捐赠科研通 6243669
什么是DOI,文献DOI怎么找? 3050999
关于科研通互助平台的介绍 2055433
邀请新用户注册赠送积分活动 2028803